Exploring the role of psychedelic-assisted therapy in enhancing spirituality and mystical experiences in patients with life-threatening illnesses: A systematic review.
Ana Esteves Ferreira, Paulo Reis-Pina
Journal of psychosomatic research February 1, 2025 DOI: 10.1016/j.jpsychores.2024.112020 via PubMed
Summary
AI-generated from the abstractA systematic review of six studies involving 140 patients, most with cancer, found that psychedelic-assisted therapy, particularly with psilocybin, enhances spirituality, mystical experiences, and spiritual well-being in people with life-threatening illnesses. Spiritual well-being improved in all studies that measured it, and mystical experiences were linked to spiritual gains in one study. The evidence comes from studies with a high risk of bias, all conducted in the United States. The review highlights the potential of this therapy to address unmet spiritual needs in palliative care, but calls for more research on how it works and how clinicians can safely guide patients through treatment.
Study at a glance
| Characteristics | Systematic review Peer reviewed |
|---|---|
| Sample size | 140 |
| Population | Patients with life-threatening illnesses, majority having cancer |
| Interventions | Psychedelic-assisted therapy psilocybin |
| Keywords | Psychedelics hallucinogens Entheogens Hospice care Terminal care |
| Citations | 3 |
| Key finding | Psychedelic-assisted therapy, especially with psilocybin, significantly improves spirituality, mystical experiences, and spiritual well-being in patients with life-threatening illnesses. |
Abstract
Psychedelic-Assisted Therapy (PAT) is gaining traction as a novel approach to addressing the psychological and existential distress experienced by patients. This systematic review aimed to investigate the impact of PAT on spirituality, mystical experiences, and spiritual well-being (SpWB) in patients with life-threatening, incurable, or terminal illnesses. A comprehensive search was conducted across PubMed, Web of Science, and Cochrane databases to identify relevant studies published between 2013 and 2023. The study population comprised patients diagnosed with life-threatening illnesses. Various forms of PAT, encompassing both typical and atypical psychedelic substances, were considered as interventions, with no specific comparators outlined. The primary outcomes of interest included spirituality, mystical experience, and SpWB. Risk of bias assessment was performed using Cochrane's tools. Six studies with a high risk of bias were included in the review, all conducted in the United States of America, involving 140 patients, the majority of whom had cancer (99 %). PAT, especially with psilocybin, demonstrated significant enhancements in spirituality, mystical experiences, and SpWB. Notably, SpWB showed improvements in all studies which assessed this spiritual outcome following PAT. Mystical experiences were correlated with improvements in spirituality in one study. This systematic review underscores the potential of PAT to address unmet spiritual needs and enhance SpWB in patients with life-threatening illnesses. However, further research is needed to elucidate the mechanisms underlying these therapeutic effects. Rigorous evaluation of healthcare practitioners' role in guiding patients through PAT protocols is essential to ensure safe and effective implementation in palliative care settings.